Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Full Evidence Review

Previous related pageVitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Study SummaryNext related pageVitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Study Summary
Study at a glance

What was studied?

This review compares gut, lung and skin barrier studies in cells, mice and people. Researchers measured passage of tracked substances, water loss, resistance to an electrical current and proteins at connections between cells. These tests describe different barrier properties.

What was found?

Some mouse and cell experiments showed worse barrier function with low vitamin D supply or loss of its receptor, the protein enabling cells to respond. In one gut model, mice whose receptor gene was deleted already had more passage of a tracked substance before injury. A dietary lung study did not show a clear initial barrier defect. Active hormone reduced water loss in mice with inflamed skin. Human trials did not clearly establish the expected barrier benefit.

What does it mean?

Effects depended on tissue, injury and measurement. A junction protein change is not automatically better exclusion of harmful material. More inflammatory cells do not by themselves prove leakage.

What are the limits?

Genetic receptor loss, dietary deficiency and active-hormone treatment are different experiments. The findings do not establish that all low vitamin D states cause leakage or that supplements prevent infection. Research amounts are not personal treatment doses.

Read the full article below ↓

Vitamin D signalling can influence epithelial barriers, but gut, lung and skin experiments do not establish one universal failure state or one supplement response. Direct permeability tests, water loss, junction proteins and circulating antibodies measure different properties. Dietary deficiency, receptor deletion and active-hormone treatment also test different causal questions. This review compares those distinctions and the limits of human intervention evidence. Read the shorter counterpart, Vitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Study Summary.

A barrier is a tissue function, not a single protein

Epithelia form interfaces between the body and its surroundings. Gut, airway and skin barriers have different structures and exposures. Their integrity includes selective passage of water and solutes, resistance to damaging material and interactions with immune defences. A barrier must perform its normal selective function; an increase in every junction protein is not automatically improvement. Vitamin D and Barrier Immunity introduces the physiological territory.

This review asks how vitamin D-related perturbations affect barrier integrity across those interfaces, and when low signalling changes susceptibility to injury, infection or inflammation. Seven central study programmes provide materially different tests, with an additional airway-cell study used for a bounded qualitative comparison. The question is cross-tissue failure and measurement, rather than another separate gut, skin or airway monograph. [1] [2] [3] [4] [5] [6] [7] [8]

Some experiments directly measure tracer movement or water loss. Others measure electrical resistance, protein distribution or blood antibodies that may reflect microbial exposure. These results should not be pooled as identical demonstrations of a sealed or leaking barrier. The human and experimental settings also require separate interpretation.

Deficiency, receptor loss and pharmacology are different interventions

Dietary vitamin D deficiency reduces supply in a whole organism. Deleting the vitamin D receptor removes a response mechanism and can affect development and systemic physiology. Adding calcitriol, the active hormone, directly to a culture or skin bypasses earlier metabolic steps. A receptor agonist such as paricalcitol is another pharmacological intervention, not ordinary vitamin D3 supplementation. [1] [2] [8]

These approaches can reveal mechanisms, but they do not identify interchangeable causes or treatments. A genetic defect may be more severe or qualitatively different from low circulating 25-hydroxyvitamin D. Benefit from pretreating a model with active hormone does not show that low nutritional status caused its failure. Likewise, correcting a nutritional state need not reverse every consequence of lifelong receptor absence.

The context of injury is equally important. An abnormal response after chemical colitis or microbial challenge is not evidence that every unchallenged tissue is spontaneously permeable. A relevant negative comparison comes from dietary lung experiments, discussed below. Preserving both baseline and challenge settings is essential to the failure-state question.

Gut injury: functional leakage with important causal limits

Li and colleagues examined deficient-diet mice, whole-body receptor deletion and chemically induced colitis. Before chemical injury, the whole-body receptor-knockout mice already had higher passage of the fluorescent dextran probe. Both dietary deficiency and receptor loss changed selected junction measures at baseline, although this does not establish a clear dietary-deficiency-only baseline tracer difference. After injury, the low-supply and receptor-loss models showed worse disease, tissue injury and fluorescent-dextran passage. The dextran experiment provides a functional permeability measurement alongside junction-protein observations. It is more informative about passage than expression alone. [1]

The study also used epithelial cultures, organoids, paricalcitol and Notch-pathway interventions. These support involvement of vitamin-D-receptor-related regulation in this model, but not one exclusive mechanism. Whole-body deletion and a mineral-rescue diet do not isolate an effect originating only in epithelial cells. Chemical colitis also does not recreate all features of human inflammatory bowel disease.

The molecular evidence needs precise wording. Promoter prediction and a luciferase reporter can support a transcriptional hypothesis, but do not demonstrate physical receptor occupancy of that promoter. The authors themselves identified further binding and rescue work as needed. This review therefore does not call direct promoter binding established by those assays. [1]

Schedules also differed. The paricalcitol arm used a longer, repeated injury timeline than the principal deficiency and knockout comparison. Its response should not be presented as a directly interchangeable reversal of the same seven-day experiment. The more detailed intestinal mechanisms remain in Intestinal VDR, Barrier Function and Microbial Metabolism: Evidence Review; the present contribution is the comparison between perturbation, challenge and actual barrier endpoint.

Junction regulation does not have one favourable direction

Zhang and colleagues studied the junction gene CLDN2, which encodes claudin-2. Their mouse and cell experiments included genetic perturbation, receptor manipulation, promoter constructs and chromatin-binding evidence. They supported direct transcriptional regulation by the vitamin D receptor: receptor loss reduced claudin-2, while active-hormone or receptor stimulation increased it. [4]

Claudin-2 is associated with junction pores. Its increase cannot automatically be called tighter exclusion of pathogens or all solutes. The study establishes a specific molecular target more directly than it establishes the net functional barrier response to oral supplementation. Calling every rise in a junction constituent beneficial would erase the protein’s particular role.

This also illustrates why different promoter experiments must not be given the same evidential label. The CLDN2 study included physical chromatin and construct evidence; Li’s reporter-based Notch inference was narrower. Multiple molecular assays strengthen a target relationship but still do not supply a patient infection or permeability outcome. [4]

Pathogen-associated barrier failure was tested experimentally

Lobo de Sá and colleagues examined Campylobacter-associated epithelial injury using cell layers, altered mice and reused human transcriptomic material. The cell experiments used calcitriol pretreatment and measured electrical resistance, small-tracer permeability and viable bacterial movement across the layer. Active hormone preserved selected functional measures and reduced bacterial transmigration under those conditions. [5]

The functional result did not require every total junction protein to rise. Protein location and the organisation of the layer can matter alongside abundance. Conversely, less bacterial movement through an experimental layer does not establish prevention or treatment of enteritis in people. The models included tumour-derived cell lines, a high active-hormone exposure and genetically or microbiologically altered mice.

The publication’s cell, mouse and human arms are not three independent clinical confirmations. The patient expression dataset and some animals were shared with earlier work. Mouse methods also describe the vitamin D reagent inconsistently, so this review does not silently assign a precise chemical identity or translate that arm into dosing advice. The unambiguous cell calcitriol experiment supplies the bounded functional comparison. [5]

This connects to Vitamin D and Mucosal Defence: restricting passage and controlling microbes are related but separate defences. Direct bacterial killing, epithelial resistance and the risk of infection should remain distinct. The study does not establish that a low blood vitamin D measurement caused a person’s Campylobacter infection.

Skin: improvement depended on an existing failure state

Umehara and colleagues tested topical calcitriol in a mouse dermatitis model. At the tested exposure of one nanomole once daily for four days, diseased skin showed improvement in late-day water loss and restriction of an injected tracer. These are functional measures alongside inflammation and protein staining. A lower dose did not show the same benefit. [2]

Healthy skin did not show the same water-loss improvement, and one healthy-strain comparison showed mild redness. The findings therefore concern a specified inflammatory failure state, not an automatic enhancement of every skin barrier. Nor was this a study of oral supplementation, ordinary nutritional deficiency, human eczema treatment or infection prevention.

Small male-mouse groups and incompletely established randomisation and blinding limit confidence. A duplicated primer-sequence entry for filaggrin and the reference gene also limits reconstruction of that particular transcript result. The functional water-loss and tracer evidence deserves attention without making the disputed transcript decisive. [2]

Vitamin D, Skin Barrier Function and Keratinocyte Maintenance: Evidence Review develops the skin-specific evidence, while Vitamin D and Skin provides its physiological setting. The cross-interface lesson is that water loss in an inflamed outer tissue, intestinal tracer movement and epithelial electrical resistance are informative but nonidentical outcomes. Their directions cannot be combined as one universal barrier score.

Lung deficiency altered inflammation without a clear baseline leak

Gorman and colleagues studied male mice raised on vitamin-D-replete or deficient diets, with correction of deficiency in a subset during adulthood. They examined unchallenged lungs rather than inducing infection. Deficiency increased airway macrophage counts, but the reported neutrophil increase was not statistically significant. Correction changed selected inflammatory-cell measures. [3]

Crucially, measured wet-to-dry lung weight, airway-fluid protein and selected junction staining did not establish a deficiency-associated baseline barrier defect. This separates inflammation from demonstrated physical leakage. It is a direct nutritional counterweight to assuming that every low-signal state must produce a permeable epithelium.

The null findings do not prove equivalence or exclude injury-dependent defects. The model used one sex and strain, lifelong exposure and limited barrier assays. Junction staining was not a comprehensive tracer-flux test. Some inflammatory-cell data reused and extended earlier work, so the older publication is not another independent confirmation. [3]

Rybakovsky and colleagues provide a different lung observation. In an immortalised human-derived airway-cell layer, active calcitriol altered electrical resistance and mannitol passage and partly attenuated cytokine-induced leak. This review uses only the qualitative main-text findings, not unverified graph-derived magnitudes. A pharmacological cell-layer response is compatible with the mouse baseline null because exposure, system and challenge differ. [8]

The existing Local Vitamin D Activation, Airway Defence and Epithelial Integrity: Evidence Review contains the detailed airway representation. Its relationship to Vitamin D and Lung Function should not turn a layer experiment into improved lung function or fewer respiratory infections in people. Neither the cell study nor the dietary-mouse experiment supplies those clinical outcomes.

Human trials did not clearly reproduce the experimental benefit

Raftery and colleagues randomized twenty-seven adults with Crohn’s disease in remission to vitamin D3 at 2,000 international units daily or placebo for three months. The active arm included thirteen and placebo fourteen participants. A multi-sugar urinary test measured permeability at different gastrointestinal levels; circulating antimicrobial peptides and disease markers were also assessed. [6]

Vitamin D status increased. Some permeability measures worsened within placebo but remained stable within the treated arm. However, the randomized between-group comparisons did not show a significant permeability benefit. A significant change in one arm and a nonsignificant change in the other is not itself proof of a significant treatment difference.

There were no relapses in either small group, which cannot establish relapse prevention. Comparisons based on the vitamin D concentration achieved after treatment no longer preserve randomization and cannot establish a barrier target. The trial was short and small, with participants in remission and limited severe deficiency. Its null comparisons are informative without proving that no possible patient group or regimen could benefit. [6]

Vermandere and colleagues assessed 175 participants within a larger randomized calcium and vitamin D polyp-prevention trial. The parent trial compared vitamin D3 at 1,000 international units daily and/or calcium at 1,200 milligrams daily with appropriate comparison groups. Over three to five years, supplementation did not produce a clear effect on selected circulating antibodies to bacterial flagellin and lipopolysaccharide. These were barrier-related surrogates in people with removed colon adenomas, not direct measurements of every epithelial flux. [7]

Those antibodies can reflect immune responsiveness and microbial exposure as well as permeability. The selected subset, assay limitations and exclusion of profound deficiency limit generalisation. Its longer randomized design adds a useful human qualification, but does not overturn a direct animal permeability result by vote counting. The studies test different claims. The wider organ context is Vitamin D and Gut.

The comparative conclusion

MeasurementMain interpretationLimit
Tracer or sugar passageFunctional permeability for the tested probeNot every molecule, pathogen or clinical outcome
Skin water lossA functional property of the outer barrierNot a direct gut or lung measure
Electrical resistanceIonic conductance across a cell layerNot complete selective permeability
Junction expression or distributionA structural or molecular responseDirection depends on the protein and tissue
Circulating bacterial antibodiesAn indirect exposure/immune responseNot direct measurement of all barrier leakage

The evidence supports tissue: and challenge-dependent participation of vitamin D signalling in barrier biology. It does not show that all low vitamin D states cause spontaneous leakage, that every receptor-deletion effect models nutritional deficiency or that active-hormone rescue predicts routine supplement benefit. Human randomized findings remain limited or null on their tested outcomes. No research exposure here establishes a personal treatment dose or a blood target for barrier protection.

Primary sources

[1] Li Y et al. Vitamin D/vitamin D receptor protects intestinal barrier against colitis by positively regulating Notch pathway. Frontiers in pharmacology. 2024;15:1421577. DOI: 10.3389/fphar.2024.1421577. PMID: 39130644.

[2] Umehara Y et al. Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice. International journal of molecular sciences. 2023;24(11):9347. DOI: 10.3390/ijms24119347. PMID: 37298299.

[3] Gorman S et al. Vitamin D supplementation of initially vitamin D-deficient mice diminishes lung inflammation with limited effects on pulmonary epithelial integrity. Physiological reports. 2017;5(15):e13371. DOI: 10.14814/phy2.13371. PMID: 28774952.

[4] Zhang YG et al. Tight junction CLDN2 gene is a direct target of the vitamin D receptor. Scientific reports. 2015;5:10642. DOI: 10.1038/srep10642. PMID: 26212084.

[5] Lobo de Sá FD et al. Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni. International journal of molecular sciences. 2021;22(16):8872. DOI: 10.3390/ijms22168872. PMID: 34445577.

[6] Raftery T et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. United European gastroenterology journal. 2015;3(3):294-302. DOI: 10.1177/2050640615572176. PMID: 26137304.

[7] Vermandere K et al. Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Patients with Colon Adenoma: A Randomized Clinical Trial. Cancer prevention research (Philadelphia, Pa.). 2021;14(3):393-402. DOI: 10.1158/1940-6207.CAPR-20-0461. PMID: 33229339.

[8] Rybakovsky E et al. Calcitriol modifies tight junctions, improves barrier function, and reduces TNF-α-induced barrier leak in the human lung-derived epithelial cell culture model, 16HBE 14o. Physiological reports. 2023;11(7):e15592. DOI: 10.14814/phy2.15592. PMID: 37038908.

Related reading

Original sources

Source

Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice

Here, we investigated the effects of calcitriol, an active form of vitamin D3, on an NC/Nga mouse model of atopic dermatitis.

Publication details

[2] Umehara Y et al. Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice. International journal of molecular sciences. 2023;24(11):9347. DOI: 10.3390/ijms24119347. PMID: 37298299.

Read more →
Source

Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni

The aim was to evaluate the relationship between epithelial barrier disruption, mucosal immune activation, and vitamin D (VD) treatment during C.

Publication details

[5] Lobo de Sá FD et al. Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni. International journal of molecular sciences. 2021;22(16):8872. DOI: 10.3390/ijms22168872. PMID: 34445577.

Read more →
Source

Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: Results from a randomised double-blind placebo-controlled study

Published in United European gastroenterology journal (2015).

Publication details

[6] Raftery T et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study. United European gastroenterology journal. 2015;3(3):294-302. DOI: 10.1177/2050640615572176. PMID: 26137304.

Read more →
Source

Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Patients with Colon Adenoma: A Randomized Clinical Trial

Published in Cancer prevention research (Philadelphia, Pa.) (2021).

Publication details

[7] Vermandere K et al. Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Patients with Colon Adenoma: A Randomized Clinical Trial. Cancer prevention research (Philadelphia, Pa.). 2021;14(3):393-402. DOI: 10.1158/1940-6207.CAPR-20-0461. PMID: 33229339.

Read more →
Source

Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐

Both effects were concentration dependent and active out to 168 h post‐treatment.

Publication details

[8] Rybakovsky E et al. Calcitriol modifies tight junctions, improves barrier function, and reduces TNF-α-induced barrier leak in the human lung-derived epithelial cell culture model, 16HBE 14o. Physiological reports. 2023;11(7):e15592. DOI: 10.14814/phy2.15592. PMID: 37038908.

Read more →